Dan Stevens

Dan Stevens

Company: Theragnostics

Job title: Chief Medical Officer


PARP Targeted Auger Electrons: Nanometre Scale Radiotherapy 9:00 am

Reviewing PARP enzymes; established druggable targets that are overexpressed in many cancer types Exploring how Auger electrons can be delivered directly to chromatin via PARP1 binding for cancer cell kill, whilst non-chromatin bound auger emission has minimal biological effect due to being out of range Highlighting how combination therapy offers a wide range of exciting…Read more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.